Canaccord Genuity Starts BioNTech (BNTX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
BofA/Merrill Lynch Starts BioNTech (BNTX) at Buy
November 4, 2019 6:15 AM ESTBofA/Merrill Lynch initiates coverage on BioNTech (NASDAQ: BNTX) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.91 yesterday.
... MoreUBS Starts BioNTech (BNTX) at Buy
November 4, 2019 4:27 AM ESTUBS analyst Andrew Ang initiates coverage on BioNTech (NASDAQ: BNTX) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.52 yesterday.
... MoreJPMorgan Starts BioNTech (BNTX) at Overweight
November 4, 2019 2:30 AM ESTJPMorgan analyst Cory Kasimov initiates coverage on BioNTech (NASDAQ: BNTX) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.52 yesterday.
... More